Company Filing History:
3 out of 45 
1 out of 78 Years Active: 2022-2024
Title: Takenao Yamada: Innovator in Antibody Therapeutics
Introduction
Takenao Yamada is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for hypertension and brain diseases. With a total of 3 patents, Yamada's work focuses on innovative methods that utilize monoclonal antibodies.
Latest Patents
Yamada's latest patents include groundbreaking inventions aimed at treating hypertension. One of his notable patents is for methods that utilize an anti-BMP10 monoclonal antibody or its fragments. This invention provides a therapeutic agent for hypertension and related diseases, highlighting the importance of BMP10 in human health. Another significant patent involves an antibody that binds to cell adhesion molecule 3 (CADM3). This invention encompasses various applications, including methods for diagnosing and treating brain diseases, as well as enhancing the accumulation of antibodies in the brain.
Career Highlights
Throughout his career, Takenao Yamada has worked with esteemed organizations such as Kyowa Kirin Co., Ltd. and Kagoshima University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to advancements in antibody research.
Collaborations
Yamada has collaborated with notable colleagues, including Hiroyuki Ariyama and Shinya Ogawa. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Takenao Yamada's contributions to the field of biotechnology through his patents and collaborations demonstrate his commitment to advancing medical science. His innovative approaches to antibody therapeutics hold promise for improving treatment options for various diseases.